NEXMED

Types of HRT: Patch, Gel or Tablets, Progesterone and How Treatment Works

HRT is not one medicine but a set of choices: which estrogen, which route, which progestogen and which regimen. Here is how the options differ and what the first months of treatment usually look like.

Nexmed Editorial · Updated 14 November 2026
Types of HRT: Patch, Gel or Tablets, Progesterone and How Treatment Works

Once you and your doctor decide that hormone replacement therapy (HRT) makes sense, new questions follow: a patch, a gel or tablets? Do you need progesterone too? Will you bleed? HRT is a set of choices (hormone, route, progestogen, regimen) that change how treatment feels and some of its risks. This guide explains the main types of HRT and how treatment works in practice, based on NICE, The Menopause Society, the British Menopause Society and the NHS. Whether HRT suits you at all is covered in HRT benefits and risks: is it safe?.

In short: HRT is estrogen, plus a progestogen if you still have a uterus, to protect its lining. Estrogen can go through the skin (patch, gel, spray) or be swallowed as a tablet. All routes relieve hot flushes similarly, but transdermal estrogen does not raise blood clot risk, while tablets do (about 1.6 times the risk in a large UK study). Side effects and irregular bleeding are common in the first months, so NICE recommends a review at 3 months.

What are the main types of HRT?

Which type you are offered depends on one question: do you still have a uterus (womb)?

  • Combined HRT (estrogen + progestogen) for women with a uterus. Estrogen alone makes the uterine lining (endometrium) grow, raising the risk of hyperplasia and cancer; enough progestogen prevents this.
  • Estrogen-only HRT for women who have had a total hysterectomy. With no uterus, no progestogen is needed.

Estrogen routes: HRT patch vs gel vs spray vs tablets

Modern HRT usually uses estradiol, the same molecule the ovaries make. According to the NHS:

  • Tablets are taken once a day.
  • Patches go on the skin below the waist and are changed once or twice a week, depending on the brand.
  • Gel is rubbed in once a day (arms, shoulders, inner thighs); let it dry and don't wash the area for an hour.
  • Spray goes on the inner arm or thigh once a day, without rubbing.

For hot flushes, a meta-analysis cited by The Menopause Society found no significant difference between transdermal and oral HRT. The real difference is safety.

Transdermal HRT and blood clot risk

Swallowed estrogen passes through the liver first, which affects clotting; estrogen absorbed through the skin largely avoids this.

  • NICE: VTE (clots in the legs or lungs) risk is not increased with transdermal HRT, is increased with oral HRT, and is greater with oral than transdermal.
  • Data: in a UK study of more than 80,000 women with VTE (Vinogradova et al., BMJ 2019), oral HRT was linked to higher risk (adjusted odds ratio 1.58); transdermal was not (0.93). Among tablets, estradiol carried less risk than conjugated equine estrogens.
  • NICE advises considering transdermal rather than oral HRT for women at higher VTE risk, including a BMI over 30. Stroke risk is also unlikely to rise with transdermal estrogen, but rises with oral estrogen, especially at higher doses.

The 1.58 figure is relative; the absolute increase depends on your baseline risk.

Comparison table: HRT routes

RouteProsConsMay suit
TabletSimple, once a day; combined tablets existHigher VTE risk; higher stroke risk at higher dosesWomen without clot risk factors who prefer a pill
PatchNo added clot risk; changed 1–2 times a week; combined patches existCan loosen or irritate skinHigher VTE risk (incl. BMI over 30); not wanting a daily dose
GelNo added clot risk; dose measured in pumps or sachetsDaily; drying time; others shouldn't touch the skin until dryWomen whose skin reacts to patches
SprayNo added clot risk; quick to applyDaily; wait an hour before washingWomen who dislike gels and patches
Vaginal estrogenMinimal absorption; no progestogen at low dosesTreats only genitourinary symptomsVaginal dryness, painful sex, urinary symptoms

The NHS notes that gel and spray may need stopping 4–6 weeks before an operation because of clot risk; always tell the surgical team you use HRT.

Why women with a uterus need a progestogen

"Progestogen" covers natural progesterone and synthetic progestins. Main options:

  • Micronised progesterone: identical to the body's own progesterone, a capsule taken at bedtime. The NHS describes 200 mg on days 15–26 of each cycle (sequential) or usually 100 mg on days 1–25 or daily (continuous). The Menopause Society stresses it must be adequately dosed.
  • Synthetic progestogens (e.g. norethisterone, medroxyprogesterone, dydrogesterone), in tablets and combined patches.
  • Levonorgestrel intrauterine system (HRT with Mirena coil): releases progestogen inside the uterus. The NHS says it can stay in place up to 5 years for HRT and also works as contraception, which helps in perimenopause. It may avoid systemic progestogen side effects (The Menopause Society, which notes this use is off-label in the US).

Does the progestogen change breast cancer risk? NICE says there is not enough evidence to show whether micronised progesterone or dydrogesterone differ from other progestogens.

Sequential vs continuous combined HRT: bleeding patterns

Sequential (cyclical)Continuous combined
HowEstrogen daily; progestogen 10–14 days a monthBoth hormones daily, no break
BleedingMonthly withdrawal bleedAim is none; irregular bleeding common in first 4–6 months
Usually forPerimenopause, periods still presentNo period for 12 months
Endometrium (NICE)Risk may slightly rise, more with fewer progestogen daysRisk decreases
Breast (NICE)Risk lower than continuous, higher than no HRTSlightly higher than sequential

Many women start sequential and later switch to continuous. If you still have periods, see perimenopause symptoms and how long it lasts.

Estrogen-only HRT after hysterectomy

After a total hysterectomy, NICE recommends estrogen-only HRT, by any route. If you're unsure whether your hysterectomy was total, ask, because it decides whether you need a progestogen. With a uterus, estrogen-only HRT raises endometrial cancer risk, oral or transdermal.

Vaginal estrogen for genitourinary symptoms

For vaginal dryness, painful sex and irritation, NICE recommends offering vaginal estrogen (cream, gel, tablet, pessary or ring), including to women already on systemic HRT.

  • Only a minimal amount reaches the bloodstream; serious adverse effects are very rare (NICE).
  • At low doses a progestogen is generally not needed, though endometrial data beyond a year are limited (The Menopause Society). Any postmenopausal bleeding should be checked.
  • Symptoms often return when it is stopped, but it can be restarted, and combined with moisturisers or lubricants.

After breast cancer, NICE recommends non-hormonal options first; vaginal estrogen can be considered with the oncology team if symptoms persist.

Tibolone

Tibolone is a daily tablet acting like combined HRT with a testosterone-like effect. The NHS says it may help hot flushes and low mood, though possibly less than standard HRT, and suits only women whose last period was over a year ago.

Testosterone for women in menopause: a limited indication

Guidelines are narrower than online claims:

  • NICE: consider it for low sexual desire if HRT alone is not effective.
  • Global Consensus Statement (2019, endorsed by the International Menopause Society): the only evidence-based indication is hypoactive sexual desire disorder in postmenopausal women, after other causes are assessed. Stop if no benefit by 6 months; safety data go to 24 months.
  • British Menopause Society (2026): trials show no benefit for cognition, mood or energy; check levels before and during treatment. A 1% cream is licensed for women in the UK, Australia, New Zealand and South Africa; elsewhere use is mostly off-label.

At physiological doses, side effects (acne, extra hair) are uncommon and usually reversible.

Body-identical vs "bioidentical" compounded hormones

  • Body-identical HRT: licensed estradiol and micronised progesterone, molecularly identical to your own hormones, tested and regulated.
  • Compounded "bioidentical" hormones: custom pharmacy mixtures, often marketed as natural or safer.

The Menopause Society calls the "bioidentical" label misleading and lists concerns with compounded products: minimal regulation, overdosing or underdosing, impurities, missing safety data and no risk label. Saliva or urine tests to set doses are unreliable, and preference alone doesn't justify compounded products when regulated ones exist. NICE says the safety of unregulated hormone preparations is unknown.

Starting HRT: the first appointment and side effects

Your doctor will ask about symptoms, periods, personal and family history (such as clots or breast cancer) and screening. Over 45, menopause is usually diagnosed from symptoms; see menopause symptoms, age and diagnosis. NICE asks doctors to discuss route, progestogen type, regimen and likely duration, and to use the lowest effective dose.

Common early side effects (NHS): breast tenderness, headaches, nausea and leg cramps (estrogen); mood changes, tiredness and acne (progestogen); spotting. They often settle within weeks, so the NHS suggests continuing at least 3 months if possible. Low doses can take 6–8 weeks to fully relieve hot flushes (The Menopause Society).

HRT bleeding: what is normal?

NICE says bleeding is common in the first 6 months of systemic HRT and within 3 months of changing dose or product. See a doctor promptly for bleeding outside these windows, heavier bleeding, or bleeding after a long gap. NICE recommends a review at 3 months, then yearly.

Adjusting the dose and switching HRT routes

According to the NHS, it can take time to find the right option; your doctor may change the dose, the type, or the route (for example from tablets to patches). Postmenopausal women on sequential HRT may move to continuous, and vaginal estrogen can be added if dryness persists. If symptoms don't improve or side effects persist, NICE recommends referral to a menopause specialist. Non-hormonal options are covered in hot flashes and night sweats treatment.

How to stop HRT: gradually or all at once?

There is no fixed time limit; continuing is reviewed at least yearly.

  • NICE: offer a choice of tapering or stopping immediately. Tapering may limit symptoms returning short term, but makes no long-term difference.
  • The Menopause Society: hot flushes return in about 50% of women; there is no consensus on abrupt vs gradual.
  • NHS: gradual reduction over 3–6 months is usually recommended; if symptoms persist beyond 3 months, talk to your doctor.

Tracking symptoms after each HRT change

Effects take weeks to show, so a record beats memory: note symptoms, any bleeding and the date of each change in dose, route or progestogen, and bring it to your 3-month review.

Amelie (partner app, iPhone) shows logged symptoms week by week since each HRT change (patch, gel, dose), so you can compare treatment periods. It covers patches, gels, sprays, pills, vaginal estrogen, IUDs, testosterone and non-hormonal treatments, sends patch-change and dose reminders that don't name the medicine on the lock screen, and creates a one-page PDF for your doctor. Data stays on the phone, no account; 1-week free trial, then a subscription. It doesn't diagnose or suggest doses. You can read more about this HRT tracker on amelie.health.

Conclusion

The logic of HRT is simple: estrogen for symptoms, a progestogen to protect the uterus if you have one, and a route and regimen chosen around your risks and cycle. Patches, gels and sprays avoid the extra clot risk of tablets; micronised progesterone or a levonorgestrel coil commonly protect the uterus. The first 3 months are an adjustment period, not a verdict. Track how you feel, report unexpected bleeding, and plan changes or stopping with your doctor.

Frequently asked questions

Is the HRT patch or gel better than tablets? For hot flushes they work similarly. Patches, gels and sprays don't increase blood clot risk while tablets do, so NICE suggests transdermal HRT for women at higher clot risk, including a BMI over 30.

Do I need progesterone if I take estrogen? Yes, if you still have a uterus, because estrogen alone raises the risk of endometrial cancer. After a total hysterectomy, estrogen-only HRT is usually enough.

Can the Mirena coil be used as part of HRT? Yes. A levonorgestrel coil can provide the progestogen part of HRT for up to 5 years, according to the NHS, and also works as contraception.

What is the difference between sequential and continuous combined HRT? Sequential HRT adds a progestogen for 10–14 days a month and causes a monthly bleed, suiting women still having periods. Continuous combined HRT uses both hormones daily, aiming for no bleeding, usually after 12 months without a period.

Is bleeding normal when starting HRT? According to NICE, irregular bleeding is common in the first 6 months and within 3 months of a dose or product change. Bleeding outside these windows, or heavier bleeding, should be checked promptly.

Are bioidentical hormones safer than regular HRT? Licensed body-identical HRT (estradiol and micronised progesterone) is regulated and tested. The Menopause Society does not recommend compounded "bioidentical" mixtures, because of unreliable dosing, impurities and missing safety data.

Can women take testosterone for low libido in menopause? Guidelines support it only for low sexual desire that persists despite HRT, after other causes are assessed, with levels monitored. It is not recommended for fatigue, mood or memory.

How do I stop HRT? NICE says you can taper or stop at once: tapering may reduce short-term symptom return, but long-term outcomes are the same. Plan it with your doctor.

Read next

Useful tools

Sources


Informational material, updated November 2026. It does not replace advice from your doctor.

This article is for general information only and does not replace advice from your doctor or pharmacist. Do not start, stop or change a treatment without medical supervision.

More on menopause & HRT